Although within the CN, the GM/WM was higher than expected, the GM ratio of AD/CN and DSAD/CN were 2.9 and 3.5 respectively, confirming the diagnostic ability of [18F]MK-6240 for tau. This evidence concerns the gene MAPT and Alzheimer disease.